U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Homoharringtonine

Semisynthetic derivative of harringtonine that acts as a protein synthesis inhibitor and induces APOPTOSIS in tumor cells. It is used in the treatment of MYELOID LEUKEMIA, CHRONIC.

Year introduced: 2019 (1972)

PubMed search builder options

Subheadings:

Tree Number(s): D03.132.420.500, D03.633.100.079.533.500, D03.633.400.624.500

MeSH Unique ID: D000077863

Registry Number: 6FG8041S5B

Entry Terms:

  • Omacetaxine Mepesuccinate
  • Cephalotaxine
  • Omacetaxine
  • Ceflatonin
  • Synribo
  • Homoharringtonine (3(R))-isomer

Pharmacologic Action:

Supplemental Content

Loading ...